WARFARIN

WARFARIN was reported 126980 times

WARFARIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 APPENDICOLITH 275 0.7106
1 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 979 0.6378
2 ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC 384 0.4981
3 SLEEP DISORDER THERAPY 96 0.4848
4 CALCIPHYLAXIS 739 0.4025
5 INTERNATIONAL NORMALISED RATIO ABNORMAL 1266 0.3678
6 INTERNATIONAL NORMALISED RATIO INCREASED 10398 0.3643
7 INTERNATIONAL NORMALISED RATIO DECREASED 1384 0.3415
8 ANALGESIC THERAPY 108 0.3364
9 DRUG THERAPY 107 0.3156
10 INTERNATIONAL NORMALISED RATIO FLUCTUATION 597 0.2883
11 STEROID DEPENDENCE 178 0.2027
12 CATARRH 163 0.1803
13 PROTHROMBIN TIME ABNORMAL 109 0.1577
14 COAGULATION TIME PROLONGED 229 0.1478
15 ABDOMINAL WALL HAEMATOMA 287 0.1470
16 SPINAL EPIDURAL HAEMATOMA 86 0.1460
17 PROTHROMBIN TIME PROLONGED 772 0.1289
18 VASCULAR CALCIFICATION 134 0.1257
19 RETROPERITONEAL HAEMATOMA 269 0.1216
20 COAGULATION TEST ABNORMAL 86 0.1117
21 INTRA-ABDOMINAL HAEMATOMA 135 0.1089
22 RETROPERITONEAL HAEMORRHAGE 262 0.1061
23 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 878 0.0992
24 CATHETER SITE PRURITUS 84 0.0957
25 GASTRIC HAEMORRHAGE 1083 0.0940
26 CATHETER MANAGEMENT 84 0.0934
27 HAEMATOMA MUSCLE 111 0.0926
28 BURNS SECOND DEGREE 161 0.0917
29 CARDIOACTIVE DRUG LEVEL INCREASED 120 0.0913
30 SUBDURAL HAEMORRHAGE 238 0.0869
31 HAEMORRHAGE INTRACRANIAL 1277 0.0853
32 BLOOD PHOSPHORUS INCREASED 223 0.0816
33 SUBDURAL HAEMATOMA 1149 0.0802
34 MUSCLE HAEMORRHAGE 306 0.0762
35 OCCULT BLOOD POSITIVE 149 0.0758
36 CATHETER SITE DISCHARGE 85 0.0756
37 HYPERPHOSPHATAEMIA 161 0.0748
38 CATHETER SITE ERYTHEMA 156 0.0728
39 PERITONEAL HAEMORRHAGE 101 0.0728
40 EXTRADURAL HAEMATOMA 95 0.0718
41 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 360 0.0710
42 INTRAVENTRICULAR HAEMORRHAGE 176 0.0707
43 RIGHT VENTRICULAR FAILURE 479 0.0683
44 SKIN NECROSIS 345 0.0664
45 PROTHROMBIN TIME SHORTENED 92 0.0656
46 ANTIPHOSPHOLIPID SYNDROME 105 0.0653
47 PERICARDIAL HAEMORRHAGE 139 0.0635
48 HAEMATOMA 1644 0.0634
49 VASCULAR PSEUDOANEURYSM 109 0.0625
50 COAGULOPATHY 1040 0.0624
51 CEREBELLAR HAEMORRHAGE 89 0.0622
52 HYPERPARATHYROIDISM SECONDARY 155 0.0618
53 NEPHROGENIC ANAEMIA 285 0.0615
54 CARDIOVERSION 85 0.0608
55 HYPERCOAGULATION 115 0.0603
56 PULMONARY ARTERIAL PRESSURE INCREASED 98 0.0601
57 ECCHYMOSIS 412 0.0600
58 ATRIAL TACHYCARDIA 125 0.0595
59 CATHETER SITE HAEMORRHAGE 147 0.0587
60 AORTIC STENOSIS 204 0.0585
61 HEPARIN-INDUCED THROMBOCYTOPENIA 288 0.0584
62 THERAPEUTIC AGENT TOXICITY 192 0.0575
63 MELAENA 1255 0.0570
64 FOOD INTERACTION 99 0.0561
65 CATHETER SITE PAIN 144 0.0554
66 PULMONARY ARTERIAL HYPERTENSION 792 0.0546
67 INTRA-ABDOMINAL HAEMORRHAGE 128 0.0537
68 COMPARTMENT SYNDROME 138 0.0529
69 BRAIN NATRIURETIC PEPTIDE INCREASED 162 0.0525
70 ORTHOPNOEA 167 0.0524
71 HYPOPNOEA 180 0.0518
72 ATRIAL THROMBOSIS 106 0.0512
73 ATRIAL FLUTTER 408 0.0511
74 INFUSION SITE INFECTION 118 0.0507
75 SUBARACHNOID HAEMORRHAGE 506 0.0496
76 INTRACARDIAC THROMBUS 149 0.0485
77 THROMBOSIS IN DEVICE 159 0.0485
78 BRONCHIECTASIS 323 0.0479
79 MITRAL VALVE DISEASE 84 0.0474
80 INFUSION SITE HAEMORRHAGE 156 0.0474
81 UPPER GASTROINTESTINAL HAEMORRHAGE 796 0.0473
82 HAEMATURIA 1599 0.0466
83 HAEMOTHORAX 132 0.0455
84 CARDIAC TAMPONADE 216 0.0454
85 HAEMORRHAGE SUBCUTANEOUS 161 0.0453
86 PULMONARY HYPERTENSION 944 0.0453
87 CATHETER PLACEMENT 83 0.0447
88 POTENTIATING DRUG INTERACTION 150 0.0447
89 CARDIAC FAILURE CHRONIC 190 0.0445
90 LOWER GASTROINTESTINAL HAEMORRHAGE 329 0.0445
91 DILATATION VENTRICULAR 93 0.0442
92 OXYGEN CONSUMPTION INCREASED 105 0.0439
93 EAR HAEMORRHAGE 87 0.0429
94 CEREBRAL HAEMORRHAGE 1518 0.0424
95 VENTRICULAR FIBRILLATION 470 0.0423
96 BRAIN HERNIATION 123 0.0411
97 CENTRAL VENOUS CATHETERISATION 124 0.0411
98 CARDIAC MURMUR 351 0.0405
99 HAEMOPTYSIS 1127 0.0404
100 ALCOHOL POISONING 108 0.0403
101 DRUG INTERACTION 6394 0.0403
102 BLOOD URIC ACID INCREASED 231 0.0400
103 RALES 230 0.0396
104 CARDIOGENIC SHOCK 568 0.0395
105 GASTROINTESTINAL HAEMORRHAGE 3274 0.0391
106 REBOUND ACID HYPERSECRETION 118 0.0390
107 HAEMORRHAGE 4072 0.0389
108 HAEMATOCRIT DECREASED 764 0.0385
109 RENAL HAEMORRHAGE 78 0.0383
110 NEPHROGENIC SYSTEMIC FIBROSIS 114 0.0377
111 EMBOLIC STROKE 132 0.0375
112 HAEMORRHAGIC DIATHESIS 130 0.0365
113 ATRIAL FIBRILLATION 3554 0.0365
114 CONJUNCTIVAL HAEMORRHAGE 139 0.0363
115 DUODENAL ULCER HAEMORRHAGE 104 0.0363
116 IRON DEFICIENCY 163 0.0362
117 DEVICE INFUSION ISSUE 88 0.0355
118 AORTIC VALVE INCOMPETENCE 151 0.0355
119 PULMONARY ALVEOLAR HAEMORRHAGE 199 0.0354
120 CARDIAC VALVE DISEASE 202 0.0353
121 VENTRICULAR TACHYCARDIA 581 0.0352
122 END STAGE RENAL DISEASE 638 0.0349
123 FLUID OVERLOAD 508 0.0349
124 TRANSFUSION 365 0.0348
125 HAEMORRHAGIC STROKE 269 0.0344
126 INFUSION SITE PAIN 443 0.0343
127 ORAL INTAKE REDUCED 83 0.0343
128 GASTRITIS EROSIVE 160 0.0343
129 APPENDICITIS 320 0.0342
130 DIVERTICULUM INTESTINAL HAEMORRHAGIC 76 0.0338
131 SHOCK HAEMORRHAGIC 275 0.0337
132 LEFT VENTRICULAR FAILURE 116 0.0337
133 CARDIAC FAILURE ACUTE 224 0.0336
134 CARDIAC PACEMAKER INSERTION 199 0.0334
135 TRICUSPID VALVE INCOMPETENCE 262 0.0329
136 RECTAL HAEMORRHAGE 1410 0.0328
137 INFUSION SITE ERYTHEMA 276 0.0327
138 MITRAL VALVE INCOMPETENCE 370 0.0327
139 VASCULAR DEVICE INFECTION 148 0.0326
140 AORTIC ARTERIOSCLEROSIS 83 0.0322
141 HAEMORRHAGE URINARY TRACT 82 0.0322
142 CARDIOMEGALY 388 0.0315
143 HYPOVOLAEMIC SHOCK 149 0.0311
144 HAEMORRHAGIC ANAEMIA 136 0.0309
145 DYSPNOEA EXERTIONAL 1162 0.0308
146 PLEURITIC PAIN 85 0.0308
147 BUNDLE BRANCH BLOCK LEFT 130 0.0306
148 EPISTAXIS 2261 0.0302
149 DEEP VEIN THROMBOSIS 1915 0.0294
150 CATHETER SITE INFECTION 111 0.0293
151 GASTRIC ULCER HAEMORRHAGE 161 0.0290
152 LEFT VENTRICULAR HYPERTROPHY 124 0.0289
153 CEREBRAL HAEMATOMA 95 0.0282
154 GOUT 507 0.0282
155 HAEMOGLOBIN DECREASED 2899 0.0282
156 MULTIPLE INJURIES 177 0.0281
157 CATHETERISATION CARDIAC 124 0.0279
158 RHINITIS 225 0.0279
159 PULMONARY HAEMORRHAGE 215 0.0275
160 FAECES DISCOLOURED 592 0.0273
161 HAEMATEMESIS 689 0.0272
162 PAROSMIA 205 0.0271
163 FLUID RETENTION 1380 0.0271
164 ENDOCARDITIS 139 0.0271
165 BLOOD PRESSURE SYSTOLIC DECREASED 123 0.0270
166 NEPHROPATHY 252 0.0270
167 PAIN IN JAW 763 0.0269
168 DIVERTICULUM 191 0.0269
169 BLOOD UREA INCREASED 450 0.0268
170 LEFT VENTRICULAR DYSFUNCTION 180 0.0268
171 EXERCISE TOLERANCE DECREASED 154 0.0267
172 ISCHAEMIC CARDIOMYOPATHY 82 0.0267
173 DEVICE RELATED INFECTION 411 0.0267
174 GANGRENE 160 0.0265
175 LUNG TRANSPLANT 93 0.0262
176 MOUTH HAEMORRHAGE 192 0.0262
177 RENAL FAILURE ACUTE 1110 0.0261
178 DIASTOLIC DYSFUNCTION 80 0.0259
179 RENAL FAILURE CHRONIC 199 0.0259
180 CARDIAC FAILURE CONGESTIVE 2078 0.0258
181 PNEUMONIA ASPIRATION 646 0.0258
182 CAROTID ARTERY OCCLUSION 94 0.0257
183 BLOOD BLISTER 80 0.0256
184 CARDIAC FAILURE 2049 0.0255
185 GINGIVAL PAIN 203 0.0255
186 EMBOLISM 211 0.0254
187 BREATH SOUNDS ABNORMAL 125 0.0253
188 PERIPHERAL ISCHAEMIA 103 0.0252
189 HYDROCEPHALUS 135 0.0248
190 IRON DEFICIENCY ANAEMIA 226 0.0245
191 INFUSION SITE PRURITUS 77 0.0244
192 TORSADE DE POINTES 191 0.0243
193 THROMBOSIS 1956 0.0243
194 BLOOD PRESSURE DIASTOLIC DECREASED 179 0.0242
195 PULSE ABSENT 115 0.0242
196 HYPOVOLAEMIA 141 0.0241
197 INTERNAL HAEMORRHAGE 275 0.0240
198 CONTUSION 2294 0.0238
199 HYPERVOLAEMIA 117 0.0237
200 ASCITES 693 0.0236
201 HAEMORRHOIDAL HAEMORRHAGE 115 0.0235
202 HYPERKALAEMIA 822 0.0234
203 INFUSION SITE SWELLING 147 0.0233
204 ATRIOVENTRICULAR BLOCK FIRST DEGREE 101 0.0233
205 HYPOPHOSPHATAEMIA 172 0.0232
206 POST PROCEDURAL HAEMORRHAGE 269 0.0231
207 RED CELL DISTRIBUTION WIDTH INCREASED 96 0.0231
208 ATELECTASIS 222 0.0230
209 HEART RATE IRREGULAR 519 0.0229
210 BENIGN PROSTATIC HYPERPLASIA 118 0.0228
211 URINE OUTPUT DECREASED 199 0.0227
212 OESOPHAGEAL ULCER 87 0.0226
213 PULMONARY THROMBOSIS 245 0.0224
214 HAEMARTHROSIS 200 0.0223
215 DUODENAL ULCER 157 0.0222
216 INTESTINAL ISCHAEMIA 122 0.0221
217 HYPERLIPIDAEMIA 264 0.0221
218 ARTERIOSCLEROSIS 206 0.0219
219 PURPURA 193 0.0218
220 PULMONARY EMBOLISM 2064 0.0217
221 MYASTHENIA GRAVIS 175 0.0216
222 TRANSIENT ISCHAEMIC ATTACK 726 0.0215
223 HAEMODIALYSIS 180 0.0214
224 GINGIVAL BLEEDING 292 0.0214
225 ECONOMIC PROBLEM 324 0.0214
226 PULSELESS ELECTRICAL ACTIVITY 89 0.0213
227 VENTRICULAR ARRHYTHMIA 77 0.0210
228 OEDEMA PERIPHERAL 2564 0.0210
229 DRUG TOXICITY 286 0.0210
230 ANAEMIA 4000 0.0210
231 ATRIOVENTRICULAR BLOCK COMPLETE 140 0.0209
232 ISCHAEMIC STROKE 373 0.0209
233 TROPONIN INCREASED 159 0.0209
234 MENTAL STATUS CHANGES 569 0.0205
235 BLOOD DISORDER 163 0.0203
236 ABDOMINAL TENDERNESS 101 0.0203
237 ACUTE RESPIRATORY FAILURE 391 0.0203
238 OLIGURIA 126 0.0203
239 BLOOD POTASSIUM INCREASED 327 0.0201
240 OEDEMA 1070 0.0197
241 WOUND SECRETION 77 0.0196
242 VENOUS THROMBOSIS 77 0.0196
243 BUNDLE BRANCH BLOCK RIGHT 90 0.0196
244 MULTI-ORGAN FAILURE 338 0.0195
245 OXYGEN SATURATION DECREASED 1095 0.0195
246 DERMATITIS CONTACT 220 0.0193
247 PERICARDIAL EFFUSION 444 0.0192
248 EJECTION FRACTION DECREASED 296 0.0190
249 CELLULITIS 959 0.0190
250 DIVERTICULUM INTESTINAL 83 0.0190
251 DIZZINESS POSTURAL 183 0.0189
252 REFUSAL OF TREATMENT BY PATIENT 123 0.0188
253 ANURIA 162 0.0188
254 BLOOD URINE PRESENT 357 0.0188
255 HYPOXIA 658 0.0187
256 PULMONARY OEDEMA 833 0.0186
257 CARDIAC OPERATION 159 0.0185
258 PETECHIAE 192 0.0184
259 HEAD INJURY 580 0.0183
260 BRADYCARDIA 972 0.0183
261 PLEURAL EFFUSION 1110 0.0182
262 HYPOTENSION 3639 0.0181
263 TUBULOINTERSTITIAL NEPHRITIS 335 0.0179
264 IMPAIRED QUALITY OF LIFE 255 0.0177
265 CHRONIC KIDNEY DISEASE 1347 0.0177
266 MYOCARDIAL ISCHAEMIA 201 0.0176
267 SPINAL COMPRESSION FRACTURE 146 0.0176
268 LIVER FUNCTION TEST ABNORMAL 511 0.0176
269 LACERATION 165 0.0175
270 HAEMATOCHEZIA 965 0.0175
271 HYPERTHYROIDISM 253 0.0175
272 LARGE INTESTINE POLYP 121 0.0175
273 BLOOD CREATININE INCREASED 1138 0.0174
274 SKIN ULCER 450 0.0174
275 CIRCULATORY COLLAPSE 296 0.0174
276 PULMONARY CONGESTION 229 0.0174
277 MULTIPLE ORGAN DYSFUNCTION SYNDROME 491 0.0173
278 VENTRICULAR EXTRASYSTOLES 180 0.0173
279 CEREBRAL INFARCTION 423 0.0173
280 ACUTE KIDNEY INJURY 2643 0.0173
281 BLOOD ALBUMIN DECREASED 137 0.0173
282 EYE HAEMORRHAGE 230 0.0172
283 RENAL TUBULAR NECROSIS 169 0.0172
284 ULCER 273 0.0171
285 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 894 0.0171
286 NECROSIS 95 0.0170
287 BODY HEIGHT DECREASED 182 0.0170
288 MULTIPLE MYELOMA 79 0.0169
289 ATRIOVENTRICULAR BLOCK 131 0.0169
290 STAPHYLOCOCCAL SEPSIS 83 0.0168
291 GENERALISED OEDEMA 205 0.0165
292 DIALYSIS 234 0.0165
293 HYPONATRAEMIA 927 0.0164
294 INCREASED TENDENCY TO BRUISE 151 0.0164
295 ORTHOSTATIC HYPOTENSION 285 0.0164
296 HEMIPARESIS 277 0.0163
297 DYSLIPIDAEMIA 83 0.0163
298 PERIPHERAL VASCULAR DISORDER 84 0.0163
299 RENAL FAILURE 2156 0.0162
300 CONCOMITANT DISEASE AGGRAVATED 100 0.0162
301 AORTIC ANEURYSM 123 0.0162
302 SYNCOPE 1613 0.0161
303 CARDIAC FLUTTER 104 0.0161
304 CARDIOMYOPATHY 237 0.0160
305 SEPSIS 1784 0.0160
306 BLOOD PRESSURE DECREASED 1058 0.0159
307 SPUTUM DISCOLOURED 151 0.0159
308 UROSEPSIS 146 0.0158
309 ULCER HAEMORRHAGE 107 0.0158
310 HAEMOLYSIS 122 0.0158
311 GASTRIC ULCER 300 0.0158
312 HYPERNATRAEMIA 78 0.0156
313 MYOPATHY 135 0.0156
314 DRUG LEVEL INCREASED 258 0.0156
315 ARRHYTHMIA 736 0.0155
316 RESPIRATORY FAILURE 1127 0.0154
317 BACTERIAL INFECTION 288 0.0154
318 DISSEMINATED INTRAVASCULAR COAGULATION 215 0.0153
319 SINUS BRADYCARDIA 147 0.0152
320 FREQUENT BOWEL MOVEMENTS 410 0.0152
321 FLANK PAIN 142 0.0151
322 COMPRESSION FRACTURE 81 0.0151
323 DYSPNOEA 8548 0.0151
324 HEART RATE DECREASED 530 0.0151
325 PRESYNCOPE 366 0.0150
326 DECUBITUS ULCER 122 0.0150
327 LUNG INFILTRATION 131 0.0148
328 ARTERIOSCLEROSIS CORONARY ARTERY 98 0.0148
329 ABNORMAL LOSS OF WEIGHT 100 0.0147
330 FALL 4880 0.0146
331 SUDDEN DEATH 154 0.0145
332 UNRESPONSIVE TO STIMULI 372 0.0144
333 HEART RATE ABNORMAL 80 0.0143
334 SPINAL OSTEOARTHRITIS 126 0.0143
335 BLOOD POTASSIUM DECREASED 431 0.0143
336 ANGINA UNSTABLE 93 0.0143
337 HIATUS HERNIA 185 0.0143
338 ELECTROCARDIOGRAM ABNORMAL 112 0.0143
339 ACUTE PULMONARY OEDEMA 80 0.0142
340 VASCULITIS 166 0.0142
341 ASPIRATION 156 0.0142
342 BLOOD TEST ABNORMAL 199 0.0141
343 SMALL INTESTINAL OBSTRUCTION 174 0.0141
344 RHABDOMYOLYSIS 589 0.0141
345 ELECTROCARDIOGRAM QT PROLONGED 505 0.0140
346 SUPRAVENTRICULAR TACHYCARDIA 134 0.0140
347 PRODUCTIVE COUGH 668 0.0140
348 CHOLECYSTITIS ACUTE 79 0.0139
349 ACUTE MYOCARDIAL INFARCTION 410 0.0139
350 HAEMORRHOIDS 271 0.0139
351 SLEEP APNOEA SYNDROME 265 0.0139
352 BLOOD SODIUM DECREASED 261 0.0138
353 HYPOPHAGIA 353 0.0138
354 POLYURIA 113 0.0138
355 SEASONAL ALLERGY 194 0.0137
356 BLOOD CALCIUM INCREASED 120 0.0137
357 POLYP 89 0.0136
358 CARDIAC ARREST 1121 0.0136
359 BLOOD MAGNESIUM DECREASED 117 0.0135
360 ANOREXIA 174 0.0135
361 GROIN PAIN 118 0.0134
362 RENAL IMPAIRMENT 1122 0.0133
363 RENAL CYST 106 0.0133
364 BLOOD IRON DECREASED 158 0.0133
365 OESOPHAGITIS 145 0.0133
366 HAEMODYNAMIC INSTABILITY 101 0.0132
367 CORONARY ARTERY DISEASE 400 0.0132
368 BLOOD ALKALINE PHOSPHATASE INCREASED 327 0.0132
369 LYMPHOEDEMA 91 0.0131
370 LETHARGY 757 0.0131
371 GASTROOESOPHAGEAL REFLUX DISEASE 1057 0.0131
372 GASTRITIS 345 0.0131
373 HEMIPLEGIA 109 0.0131
374 LOCALISED INFECTION 315 0.0130
375 CEREBROVASCULAR ACCIDENT 2203 0.0130
376 FACIAL PAIN 116 0.0130
377 RESPIRATORY RATE INCREASED 115 0.0129
378 GLOMERULAR FILTRATION RATE DECREASED 159 0.0129
379 DEVICE OCCLUSION 182 0.0129
380 COMA 615 0.0129
381 EMPHYSEMA 130 0.0129
382 RIB FRACTURE 265 0.0129
383 PNEUMONIA 4170 0.0129
384 CHEST PAIN 2379 0.0128
385 ACIDOSIS 98 0.0128
386 THERAPY CHANGE 126 0.0128
387 CLOSTRIDIUM DIFFICILE INFECTION 279 0.0128
388 DEHYDRATION 1704 0.0128
389 BLOOD PRESSURE SYSTOLIC INCREASED 249 0.0128
390 NEURALGIA 310 0.0127
391 HEART RATE INCREASED 1258 0.0127
392 CLOSTRIDIUM DIFFICILE COLITIS 134 0.0126
393 MUSCLE STRAIN 109 0.0126
394 BLOOD COUNT ABNORMAL 191 0.0126
395 HYPOMAGNESAEMIA 175 0.0126
396 CONFUSIONAL STATE 2021 0.0125
397 PLATELET COUNT INCREASED 163 0.0125
398 HIP FRACTURE 401 0.0125
399 PELVIC FRACTURE 96 0.0123
400 EXTRASYSTOLES 86 0.0123
401 DECREASED ACTIVITY 132 0.0122
402 RENAL INJURY 363 0.0122
403 BODY TEMPERATURE DECREASED 120 0.0122
404 LIMB INJURY 331 0.0122
405 PERIPHERAL SWELLING 1873 0.0121
406 STAPHYLOCOCCAL INFECTION 400 0.0121
407 TENDERNESS 126 0.0121
408 RED BLOOD CELL COUNT DECREASED 345 0.0121
409 ASPARTATE AMINOTRANSFERASE INCREASED 641 0.0121
410 WEIGHT FLUCTUATION 126 0.0120
411 POST PROCEDURAL COMPLICATION 231 0.0120
412 BLOOD CALCIUM DECREASED 135 0.0120
413 SHOCK 275 0.0119
414 PALPITATIONS 1394 0.0119
415 URINARY RETENTION 397 0.0119
416 INTERVERTEBRAL DISC DEGENERATION 110 0.0119
417 BLOOD LACTATE DEHYDROGENASE INCREASED 188 0.0119
418 WHITE BLOOD CELL COUNT INCREASED 454 0.0118
419 NO THERAPEUTIC RESPONSE 144 0.0118
420 HEPATOMEGALY 116 0.0118
421 MALNUTRITION 132 0.0118
422 ABDOMINAL DISTENSION 1229 0.0118
423 ASTHENIA 4424 0.0118
424 CORONARY ARTERY OCCLUSION 161 0.0117
425 BACTERAEMIA 139 0.0117
426 PEMPHIGOID 88 0.0116
427 MEDICATION ERROR 648 0.0116
428 MUSCULOSKELETAL CHEST PAIN 180 0.0116
429 SINUS CONGESTION 157 0.0116
430 LEUKOCYTOSIS 210 0.0116
431 STENT PLACEMENT 93 0.0115
432 APHASIA 348 0.0115
433 RESPIRATORY DISTRESS 318 0.0115
434 RENAL DISORDER 532 0.0114
435 PULMONARY FIBROSIS 219 0.0114
436 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 117 0.0114
437 CYANOSIS 179 0.0114
438 SKIN DISCOLOURATION 518 0.0113
439 COLITIS ISCHAEMIC 76 0.0113
440 BLOOD BILIRUBIN INCREASED 303 0.0112
441 LOWER RESPIRATORY TRACT INFECTION 510 0.0112
442 BLOOD PRESSURE FLUCTUATION 269 0.0112
443 ABASIA 276 0.0112
444 JOINT EFFUSION 77 0.0112
445 ACCIDENTAL OVERDOSE 408 0.0111
446 HEPATIC FUNCTION ABNORMAL 416 0.0111
447 CARDIO-RESPIRATORY ARREST 466 0.0111
448 IMPAIRED WORK ABILITY 238 0.0111
449 CYSTITIS 354 0.0111
450 FLUSHING 1129 0.0111
451 CARDIAC DISORDER 1037 0.0111
452 NASAL CONGESTION 651 0.0111
453 HEPATIC CIRRHOSIS 208 0.0111
454 DRUG ADMINISTRATION ERROR 337 0.0110
455 INTERSTITIAL LUNG DISEASE 531 0.0110
456 DYSARTHRIA 411 0.0109
457 PNEUMOTHORAX 173 0.0109
458 INCONTINENCE 115 0.0109
459 CHOLELITHIASIS 356 0.0108
460 HOSPICE CARE 107 0.0108
461 DEFORMITY 101 0.0108
462 PLATELET COUNT DECREASED 1147 0.0108
463 SWOLLEN TONGUE 336 0.0107
464 SEPTIC SHOCK 466 0.0107
465 RETCHING 228 0.0107
466 PROSTATIC SPECIFIC ANTIGEN INCREASED 147 0.0107
467 BLOOD CREATINE PHOSPHOKINASE INCREASED 306 0.0106
468 PNEUMONIA BACTERIAL 97 0.0106
469 PERIPHERAL COLDNESS 145 0.0105
470 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 181 0.0105
471 ELECTROLYTE IMBALANCE 122 0.0105
472 SPLENOMEGALY 123 0.0105
473 DIZZINESS 5233 0.0105
474 LUNG INFECTION 163 0.0105
475 HYPOGLYCAEMIA 508 0.0105
476 PALLOR 285 0.0105
477 TOXIC EPIDERMAL NECROLYSIS 159 0.0105
478 COLON CANCER 156 0.0105
479 COMPLICATION ASSOCIATED WITH DEVICE 152 0.0105
480 DELIRIUM 363 0.0104
481 BOWEL MOVEMENT IRREGULARITY 80 0.0104
482 OSTEOMYELITIS 189 0.0104
483 URINARY TRACT INFECTION 1774 0.0104
484 MASS 145 0.0104
485 JAUNDICE 278 0.0103
486 ARTERIAL OCCLUSIVE DISEASE 81 0.0103
487 WEIGHT DECREASED 2873 0.0103
488 ALTERED STATE OF CONSCIOUSNESS 222 0.0102
489 LOSS OF CONSCIOUSNESS 1312 0.0102
490 PHARYNGITIS 127 0.0102
491 DEPRESSED LEVEL OF CONSCIOUSNESS 404 0.0102
492 PULMONARY MASS 152 0.0102
493 UPPER-AIRWAY COUGH SYNDROME 84 0.0102
494 SENSORY LOSS 82 0.0102
495 PAIN IN EXTREMITY 2997 0.0102
496 TREATMENT NONCOMPLIANCE 556 0.0102
497 BACK DISORDER 165 0.0101
498 LOCAL SWELLING 177 0.0101
499 DIVERTICULITIS 281 0.0101
500 JOINT INJURY 216 0.0101
501 BRONCHITIS 748 0.0101
502 SWELLING 944 0.0101
503 BALANCE DISORDER 869 0.0100
504 ALANINE AMINOTRANSFERASE INCREASED 616 0.0100
505 MYOSITIS 90 0.0100
506 GAMMA-GLUTAMYLTRANSFERASE INCREASED 222 0.0100
507 HYPOKALAEMIA 462 0.0100
508 SPINAL FRACTURE 200 0.0100
509 METABOLIC ACIDOSIS 319 0.0100
510 TINNITUS 458 0.0100
511 COUGH 2792 0.0099
512 MUSCLE ATROPHY 126 0.0099
513 ROTATOR CUFF SYNDROME 127 0.0099
514 SYSTEMIC LUPUS ERYTHEMATOSUS 350 0.0099
515 SKIN LACERATION 107 0.0098
516 HYPERCHOLESTEROLAEMIA 95 0.0098
517 MUSCULOSKELETAL PAIN 515 0.0098
518 PHARMACEUTICAL PRODUCT COMPLAINT 255 0.0098
519 KIDNEY INFECTION 192 0.0098
520 ANGINA PECTORIS 280 0.0098
521 WOUND INFECTION 107 0.0098
522 DENTAL CARIES 108 0.0098
523 GALLBLADDER DISORDER 174 0.0097
524 MACULAR DEGENERATION 116 0.0097
525 CHROMATURIA 219 0.0097
526 MUSCULAR WEAKNESS 1101 0.0097
527 PSEUDOMONAS INFECTION 83 0.0097
528 DECREASED APPETITE 2248 0.0097
529 UPPER RESPIRATORY TRACT INFECTION 445 0.0096
530 TACHYCARDIA 855 0.0096
531 HYPOCALCAEMIA 182 0.0096
532 SINUS DISORDER 189 0.0095
533 BLOOD CHOLESTEROL INCREASED 444 0.0095
534 LACTIC ACIDOSIS 307 0.0095
535 ATAXIA 112 0.0094
536 SOMNOLENCE 1896 0.0094
537 ANHEDONIA 247 0.0094
538 ABDOMINAL PAIN 2178 0.0094
539 LABORATORY TEST ABNORMAL 276 0.0093
540 FEELING COLD 260 0.0093
541 ARTHRITIS 734 0.0093
542 CHOLECYSTITIS 111 0.0093
543 DYSSTASIA 272 0.0093
544 RESPIRATORY TRACT CONGESTION 148 0.0093
545 DIARRHOEA 5996 0.0093
546 FACIAL PARALYSIS 79 0.0093
547 LUNG DISORDER 454 0.0093
548 DIABETES MELLITUS 705 0.0092
549 DYSGEUSIA 687 0.0092
550 CONSTIPATION 2015 0.0092
551 NOCTURIA 112 0.0092
552 BLADDER DISORDER 91 0.0092
553 MICTURITION URGENCY 104 0.0091
554 THROMBOCYTOPENIA 1017 0.0091
555 CONTRAINDICATED PRODUCT ADMINISTERED 270 0.0089
556 URINARY INCONTINENCE 264 0.0089
557 BLOOD PRESSURE ABNORMAL 177 0.0089
558 EAR DISCOMFORT 91 0.0089
559 HYPOTHYROIDISM 283 0.0089
560 WRIST FRACTURE 106 0.0088
561 DYSPHONIA 514 0.0088
562 FULL BLOOD COUNT DECREASED 177 0.0088
563 CHEST DISCOMFORT 898 0.0088
564 DRY THROAT 89 0.0087
565 UNEVALUABLE EVENT 662 0.0087
566 BACK PAIN 2022 0.0087
567 LIGAMENT SPRAIN 86 0.0087
568 CONDITION AGGRAVATED 2643 0.0087
569 C-REACTIVE PROTEIN INCREASED 316 0.0087
570 FLATULENCE 492 0.0087
571 ENCEPHALOPATHY 213 0.0087
572 POLLAKIURIA 361 0.0086
573 GENERAL PHYSICAL HEALTH DETERIORATION 1000 0.0086
574 TOOTH ABSCESS 88 0.0086
575 MYOCLONUS 103 0.0086
576 BEDRIDDEN 113 0.0086
577 DRY MOUTH 695 0.0086
578 DIARRHOEA HAEMORRHAGIC 80 0.0085
579 RESPIRATORY ARREST 235 0.0085
580 ABDOMINAL DISCOMFORT 1419 0.0085
581 ANAL INCONTINENCE 76 0.0084
582 ACTIVITIES OF DAILY LIVING IMPAIRED 167 0.0084
583 LIVER DISORDER 374 0.0084
584 DIPLOPIA 219 0.0084
585 MUSCULOSKELETAL DISCOMFORT 145 0.0084
586 HYPERCALCAEMIA 104 0.0084
587 PROTEINURIA 160 0.0084
588 BONE DISORDER 153 0.0084
589 ACUTE RESPIRATORY DISTRESS SYNDROME 148 0.0084
590 INTESTINAL OBSTRUCTION 315 0.0083
591 UPPER LIMB FRACTURE 166 0.0083
592 IMPAIRED HEALING 273 0.0083
593 MALAISE 3643 0.0083
594 SQUAMOUS CELL CARCINOMA 78 0.0083
595 SCIATICA 132 0.0083
596 RASH GENERALISED 214 0.0083
597 COLD SWEAT 145 0.0082
598 ORAL PAIN 184 0.0082
599 SKIN INFECTION 92 0.0082
600 OSTEOARTHRITIS 347 0.0082
601 CATARACT 486 0.0082
602 HEPATIC STEATOSIS 152 0.0082
603 BLINDNESS UNILATERAL 115 0.0081
604 OSTEOPOROSIS 335 0.0081
605 WHEEZING 482 0.0081
606 ORAL CANDIDIASIS 107 0.0081
607 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 390 0.0081
608 PARALYSIS 116 0.0081
609 BACK INJURY 88 0.0081
610 RHINORRHOEA 522 0.0081
611 OROPHARYNGEAL PAIN 747 0.0081
612 INTRAOCULAR PRESSURE INCREASED 103 0.0081
613 FATIGUE 6262 0.0080
614 TOOTH EXTRACTION 100 0.0080
615 HYPERSOMNIA 230 0.0080
616 PLASMA CELL MYELOMA 313 0.0080
617 SKIN LESION 220 0.0080
618 TACHYPNOEA 109 0.0080
619 DEAFNESS 209 0.0080
620 WOUND 223 0.0080
621 NIGHTMARE 276 0.0080
622 NEUROPATHY PERIPHERAL 757 0.0080
623 VISUAL ACUITY REDUCED 264 0.0079
624 VERTIGO 484 0.0079
625 GAIT DISTURBANCE 1516 0.0079
626 RESTLESS LEGS SYNDROME 144 0.0079
627 VOMITING 3720 0.0079
628 PANCYTOPENIA 442 0.0079
629 SECRETION DISCHARGE 99 0.0079
630 VITAMIN D DEFICIENCY 77 0.0079
631 TOOTH INFECTION 104 0.0079
632 NECK PAIN 439 0.0078
633 DYSURIA 289 0.0078
634 OSTEOPENIA 119 0.0078
635 DEMENTIA 219 0.0078
636 NEUTROPHIL COUNT INCREASED 80 0.0078
637 HYPOTHERMIA 79 0.0078
638 DISORIENTATION 309 0.0078
639 HYPOKINESIA 113 0.0078
640 HEPATIC FAILURE 234 0.0078
641 BASAL CELL CARCINOMA 121 0.0077
642 JOINT RANGE OF MOTION DECREASED 104 0.0077
643 GASTRIC DISORDER 266 0.0077
644 AMNESIA 504 0.0077
645 MYOCARDIAL INFARCTION 1348 0.0077
646 HALLUCINATION, VISUAL 163 0.0077
647 ABSCESS 123 0.0077
648 LIMB DISCOMFORT 238 0.0077
649 ILEUS 95 0.0076
650 NAUSEA 6040 0.0076
651 SKIN HAEMORRHAGE 113 0.0076
652 HYPERTENSION 1611 0.0076
653 HEADACHE 4768 0.0076
654 VIRAL INFECTION 253 0.0076
655 BRAIN OEDEMA 96 0.0076
656 MYALGIA 1292 0.0076
657 INTENTIONAL PRODUCT USE ISSUE 665 0.0076
658 PRURITUS GENERALISED 164 0.0076
659 MOBILITY DECREASED 544 0.0076
660 OBSTRUCTIVE AIRWAYS DISORDER 84 0.0075
661 SCAB 86 0.0075
662 HALLUCINATION 567 0.0075
663 DYSPHAGIA 714 0.0075
664 TOXICITY TO VARIOUS AGENTS 1266 0.0075
665 GASTROENTERITIS VIRAL 135 0.0075
666 GASTROENTERITIS 109 0.0075
667 PYREXIA 2569 0.0074
668 BURSITIS 90 0.0074
669 ARTHROPATHY 412 0.0074
670 DYSPEPSIA 729 0.0074
671 BODY TEMPERATURE INCREASED 151 0.0074
672 WEIGHT INCREASED 1655 0.0074
673 BLOOD PRESSURE INCREASED 1127 0.0074
674 INFLUENZA 822 0.0074
675 COMPLETED SUICIDE 614 0.0074
676 NODULE 96 0.0073
677 PREMATURE DELIVERY 117 0.0073
678 ADRENAL INSUFFICIENCY 89 0.0073
679 TOOTH DISORDER 163 0.0073
680 RESPIRATORY TRACT INFECTION 190 0.0073
681 DRUG PRESCRIBING ERROR 140 0.0073
682 PNEUMONITIS 198 0.0073
683 COLITIS ULCERATIVE 325 0.0073
684 RASH PRURITIC 394 0.0073
685 SNEEZING 163 0.0073
686 DRUG DISPENSING ERROR 111 0.0073
687 MYELODYSPLASTIC SYNDROME 105 0.0073
688 FEMUR FRACTURE 224 0.0072
689 INJURY 507 0.0072
690 MUSCULOSKELETAL DISORDER 137 0.0072
691 NEPHROLITHIASIS 330 0.0072
692 NASOPHARYNGITIS 1326 0.0072
693 HERNIA 139 0.0072
694 KNEE ARTHROPLASTY 151 0.0072
695 EATING DISORDER 152 0.0071
696 THYROID DISORDER 110 0.0071
697 ABDOMINAL PAIN LOWER 180 0.0071
698 METASTASES TO BONE 116 0.0071
699 INTERVERTEBRAL DISC PROTRUSION 154 0.0070
700 BLISTER 390 0.0069
701 HYPERGLYCAEMIA 253 0.0069
702 PERICARDITIS 116 0.0069
703 SPEECH DISORDER 361 0.0069
704 ABDOMINAL PAIN UPPER 1416 0.0069
705 BLOOD TRIGLYCERIDES INCREASED 121 0.0068
706 SCAR 117 0.0068
707 DISEASE PROGRESSION 808 0.0068
708 THIRST 122 0.0068
709 MUSCLE TIGHTNESS 110 0.0068
710 JOINT SWELLING 819 0.0068
711 HOSPITALISATION 1036 0.0067
712 BONE MARROW FAILURE 137 0.0067
713 AGEUSIA 168 0.0067
714 SKIN CANCER 145 0.0067
715 QUALITY OF LIFE DECREASED 90 0.0067
716 TOOTHACHE 121 0.0067
717 FEELING ABNORMAL 1599 0.0067
718 BLINDNESS 271 0.0066
719 HYPERHIDROSIS 856 0.0066
720 HERPES ZOSTER 381 0.0066
721 LIP SWELLING 220 0.0066
722 RASH MACULAR 230 0.0066
723 INFECTION 952 0.0066
724 CHILLS 771 0.0066
725 DRUG-INDUCED LIVER INJURY 205 0.0065
726 LIVER FUNCTION TEST INCREASED 140 0.0065
727 THERAPY NON-RESPONDER 293 0.0065
728 OSTEONECROSIS OF JAW 161 0.0065
729 EOSINOPHILIA 114 0.0065
730 DRUG INTOLERANCE 627 0.0065
731 GLAUCOMA 125 0.0065
732 CONVULSION 371 0.0065
733 THROAT IRRITATION 290 0.0065
734 LOWER LIMB FRACTURE 124 0.0064
735 RESPIRATORY DISORDER 193 0.0064
736 APHONIA 90 0.0064
737 CYST 80 0.0064
738 HYPOACUSIS 277 0.0064
739 MEMORY IMPAIRMENT 883 0.0064
740 COGNITIVE DISORDER 300 0.0064
741 PHOTOSENSITIVITY REACTION 106 0.0064
742 TREMOR 1063 0.0064
743 HIP ARTHROPLASTY 98 0.0064
744 COORDINATION ABNORMAL 89 0.0064
745 CARPAL TUNNEL SYNDROME 89 0.0063
746 HAIR COLOUR CHANGES 79 0.0063
747 OBESITY 101 0.0063
748 SINUS TACHYCARDIA 90 0.0063
749 THERAPY CESSATION 325 0.0063
750 ANKLE FRACTURE 98 0.0063
751 INTENTIONAL PRODUCT MISUSE 554 0.0063
752 EAR PAIN 123 0.0063
753 INSOMNIA 1669 0.0063
754 SKIN DISORDER 209 0.0063
755 SLEEP DISORDER 441 0.0062
756 FEELING HOT 383 0.0062
757 LYMPHOCYTE COUNT DECREASED 110 0.0062
758 MUSCLE SPASMS 1140 0.0062
759 HAIR TEXTURE ABNORMAL 83 0.0062
760 TENDONITIS 96 0.0062
761 PAIN 3802 0.0062
762 MIGRAINE 590 0.0062
763 DEVICE FAILURE 94 0.0062
764 BLOOD GLUCOSE ABNORMAL 114 0.0062
765 FOOT FRACTURE 117 0.0062
766 VISION BLURRED 841 0.0061
767 FEEDING DISORDER 124 0.0061
768 CANDIDA INFECTION 103 0.0061
769 SWELLING FACE 397 0.0061
770 METASTASES TO LIVER 107 0.0061
771 MUSCLE TWITCHING 140 0.0061
772 ORAL DISCOMFORT 84 0.0060
773 HYPOAESTHESIA ORAL 91 0.0060
774 CHOKING 117 0.0060
775 NIGHT SWEATS 193 0.0060
776 PRODUCT DOSE OMISSION 388 0.0059
777 SINUSITIS 609 0.0059
778 WHITE BLOOD CELL COUNT DECREASED 644 0.0059
779 STEVENS-JOHNSON SYNDROME 132 0.0059
780 TRANSAMINASES INCREASED 132 0.0059
781 BLOOD GLUCOSE DECREASED 285 0.0059
782 OSTEONECROSIS 194 0.0059
783 MUSCULOSKELETAL STIFFNESS 514 0.0059
784 ROAD TRAFFIC ACCIDENT 245 0.0059
785 MOVEMENT DISORDER 188 0.0058
786 PHOTOPHOBIA 110 0.0058
787 PRODUCT ADMINISTRATION ERROR 118 0.0058
788 FUNGAL INFECTION 194 0.0058
789 TASTE DISORDER 118 0.0058
790 SENSORY DISTURBANCE 93 0.0058
791 GASTROINTESTINAL DISORDER 519 0.0058
792 DRUG DOSE OMISSION 955 0.0058
793 AGRANULOCYTOSIS 107 0.0058
794 DRUG ERUPTION 102 0.0058
795 ARTHRALGIA 2391 0.0057
796 FEAR 154 0.0057
797 CARDIOVASCULAR DISORDER 145 0.0057
798 BONE PAIN 332 0.0057
799 HYPOAESTHESIA 845 0.0056
800 HOT FLUSH 424 0.0056
801 RASH 2451 0.0056
802 HEPATIC ENZYME INCREASED 380 0.0056
803 ADVERSE EVENT 512 0.0056
804 DEATH 4785 0.0055
805 FIBROMYALGIA 135 0.0055
806 HEPATITIS 142 0.0055
807 ANXIETY 1572 0.0055
808 PRODUCT SUBSTITUTION ISSUE 318 0.0055
809 PANCREATITIS ACUTE 124 0.0055
810 GAIT INABILITY 184 0.0055
811 EYE PAIN 310 0.0055
812 DRUG RESISTANCE 141 0.0055
813 POOR QUALITY SLEEP 118 0.0055
814 LYMPHADENOPATHY 194 0.0055
815 RASH ERYTHEMATOUS 262 0.0055
816 DIABETES MELLITUS INADEQUATE CONTROL 97 0.0055
817 NERVOUSNESS 285 0.0054
818 JOINT STIFFNESS 143 0.0054
819 BURNING SENSATION 382 0.0054
820 SURGERY 318 0.0054
821 DEPRESSION 1233 0.0054
822 MIDDLE INSOMNIA 101 0.0054
823 PHARYNGEAL OEDEMA 83 0.0054
824 ANOSMIA 78 0.0054
825 AGITATION 395 0.0054
826 ERECTILE DYSFUNCTION 138 0.0054
827 VAGINAL HAEMORRHAGE 233 0.0054
828 DRUG EFFECT DECREASED 287 0.0053
829 ERUCTATION 103 0.0053
830 MENTAL IMPAIRMENT 129 0.0053
831 PREMATURE BABY 160 0.0053
832 CHOLESTASIS 102 0.0053
833 ECZEMA 276 0.0053
834 DYSKINESIA 214 0.0053
835 BLOOD GLUCOSE INCREASED 992 0.0053
836 RASH PAPULAR 118 0.0053
837 HEAD DISCOMFORT 93 0.0052
838 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 373 0.0052
839 ERYTHEMA 1077 0.0052
840 PARAESTHESIA 823 0.0052
841 DELUSION 81 0.0052
842 LIVER INJURY 127 0.0052
843 COLITIS 195 0.0051
844 ADVERSE DRUG REACTION 462 0.0051
845 ANGIOEDEMA 226 0.0051
846 LACRIMATION INCREASED 154 0.0051
847 MENORRHAGIA 100 0.0051
848 TYPE 2 DIABETES MELLITUS 171 0.0051
849 GLYCOSYLATED HAEMOGLOBIN INCREASED 128 0.0051
850 EYE DISORDER 166 0.0050
851 THINKING ABNORMAL 94 0.0050
852 FRACTURE 95 0.0050
853 DISCOMFORT 306 0.0050
854 VISUAL IMPAIRMENT 621 0.0050
855 DERMATITIS 105 0.0050
856 DEVICE DISLOCATION 215 0.0049
857 FACE OEDEMA 83 0.0049
858 PAIN OF SKIN 132 0.0049
859 LEUKOPENIA 244 0.0049
860 CYTOMEGALOVIRUS INFECTION 81 0.0049
861 PRODUCT PRESCRIBING ERROR 116 0.0049
862 PRURITUS 1858 0.0048
863 STOMATITIS 293 0.0048
864 NEUTROPENIA 655 0.0048
865 RASH MACULO-PAPULAR 107 0.0048
866 NERVOUS SYSTEM DISORDER 150 0.0048
867 HEPATOTOXICITY 106 0.0048
868 INCORRECT DRUG ADMINISTRATION DURATION 133 0.0047
869 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 121 0.0047
870 UNDERDOSE 342 0.0047
871 GLOSSODYNIA 104 0.0046
872 PANCREATITIS 245 0.0046
873 PERITONITIS 96 0.0046
874 OFF LABEL USE 4031 0.0046
875 MOUTH ULCERATION 97 0.0046
876 DISTURBANCE IN ATTENTION 248 0.0046
877 LUNG NEOPLASM MALIGNANT 188 0.0046
878 FEELING JITTERY 87 0.0046
879 TOOTH LOSS 94 0.0045
880 INFLAMMATION 234 0.0045
881 EAR INFECTION 120 0.0045
882 ABNORMAL DREAMS 124 0.0045
883 PARANOIA 76 0.0044
884 COVID-19 773 0.0044
885 ALOPECIA 864 0.0044
886 INCREASED APPETITE 84 0.0044
887 DEPRESSED MOOD 232 0.0044
888 BONE DENSITY DECREASED 137 0.0044
889 NEUTROPHIL COUNT DECREASED 178 0.0044
890 ASTHMA 492 0.0043
891 INTENTIONAL DRUG MISUSE 91 0.0043
892 OVERDOSE 930 0.0043
893 RESTLESSNESS 157 0.0043
894 PRESCRIBED UNDERDOSE 85 0.0043
895 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 99 0.0042
896 MATERNAL EXPOSURE DURING PREGNANCY 377 0.0042
897 INFLUENZA LIKE ILLNESS 347 0.0042
898 IRRITABLE BOWEL SYNDROME 90 0.0042
899 PRODUCT QUALITY ISSUE 569 0.0042
900 SEIZURE 480 0.0042
901 DISABILITY 82 0.0041
902 INJECTION SITE HAEMORRHAGE 329 0.0041
903 EYE SWELLING 152 0.0041
904 ILL-DEFINED DISORDER 248 0.0041
905 INFUSION RELATED REACTION 270 0.0041
906 HYPERSENSITIVITY 756 0.0041
907 DEVICE LEAKAGE 176 0.0041
908 DISEASE RECURRENCE 193 0.0041
909 DRUG EFFECT INCOMPLETE 146 0.0040
910 PRODUCT USE IN UNAPPROVED INDICATION 995 0.0040
911 SEDATION 105 0.0040
912 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 717 0.0040
913 DRUG INEFFECTIVE 5241 0.0040
914 THERAPEUTIC RESPONSE UNEXPECTED 178 0.0040
915 PRODUCT USE ISSUE 734 0.0039
916 EYE PRURITUS 131 0.0039
917 RHEUMATOID ARTHRITIS 442 0.0039
918 MENTAL DISORDER 169 0.0039
919 NEOPLASM MALIGNANT 256 0.0038
920 OCULAR HYPERAEMIA 182 0.0038
921 ABNORMAL BEHAVIOUR 151 0.0038
922 ANAPHYLACTIC SHOCK 98 0.0038
923 MALIGNANT NEOPLASM PROGRESSION 386 0.0038
924 SKIN EXFOLIATION 317 0.0038
925 WRONG TECHNIQUE IN DRUG USAGE PROCESS 135 0.0037
926 FEBRILE NEUTROPENIA 244 0.0037
927 THERAPEUTIC RESPONSE DECREASED 222 0.0037
928 INCORRECT DOSE ADMINISTERED 827 0.0036
929 DIABETIC KETOACIDOSIS 87 0.0036
930 EXPOSURE DURING PREGNANCY 224 0.0036
931 AGGRESSION 179 0.0036
932 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 196 0.0036
933 PSYCHOTIC DISORDER 105 0.0036
934 DRY EYE 177 0.0035
935 PRODUCT AVAILABILITY ISSUE 79 0.0035
936 EXPIRED PRODUCT ADMINISTERED 115 0.0035
937 DEVICE MALFUNCTION 243 0.0035
938 SUICIDE ATTEMPT 208 0.0034
939 URTICARIA 574 0.0034
940 TREATMENT FAILURE 283 0.0034
941 EMOTIONAL DISORDER 105 0.0034
942 ILLNESS 344 0.0033
943 DEVICE ISSUE 299 0.0033
944 DRY SKIN 445 0.0033
945 PROCEDURAL PAIN 92 0.0033
946 EMOTIONAL DISTRESS 398 0.0033
947 IRRITABILITY 197 0.0033
948 PANIC ATTACK 119 0.0033
949 INJECTION SITE BRUISING 260 0.0033
950 NEOPLASM PROGRESSION 113 0.0032
951 INTENTIONAL DOSE OMISSION 92 0.0032
952 THERAPY INTERRUPTED 229 0.0032
953 EYE IRRITATION 184 0.0032
954 MUCOSAL INFLAMMATION 82 0.0031
955 THROAT TIGHTNESS 84 0.0031
956 ANGER 105 0.0031
957 SUICIDAL IDEATION 284 0.0031
958 MOOD ALTERED 83 0.0030
959 PRODUCT DOSE OMISSION IN ERROR 85 0.0030
960 INTENTIONAL OVERDOSE 192 0.0030
961 FOETAL EXPOSURE DURING PREGNANCY 239 0.0029
962 NEEDLE ISSUE 85 0.0029
963 EXTRA DOSE ADMINISTERED 115 0.0028
964 EPILEPSY 86 0.0028
965 DEVICE BREAKAGE 110 0.0027
966 CRYING 97 0.0027
967 GYNAECOMASTIA 78 0.0025
968 ABORTION SPONTANEOUS 101 0.0025
969 ANAPHYLACTIC REACTION 135 0.0024
970 PRODUCT DOSE OMISSION ISSUE 697 0.0024
971 INJECTION SITE MASS 86 0.0023
972 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 469 0.0023
973 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 164 0.0023
974 PSORIASIS 298 0.0023
975 INJECTION SITE ERYTHEMA 275 0.0022
976 WITHDRAWAL SYNDROME 87 0.0021
977 THERAPEUTIC PRODUCT EFFECT DECREASED 89 0.0020
978 INJECTION SITE SWELLING 150 0.0020
979 PSORIATIC ARTHROPATHY 78 0.0019
980 INJECTION SITE PAIN 567 0.0018
981 SKIN IRRITATION 81 0.0018
982 INJECTION SITE PRURITUS 118 0.0018
983 SKIN BURNING SENSATION 125 0.0017
984 PROSTATE CANCER 135 0.0017
985 BREAST CANCER 156 0.0017
986 MULTIPLE SCLEROSIS 77 0.0016
987 INJECTION SITE REACTION 108 0.0016
988 BLADDER CANCER 92 0.0016
989 ACNE 112 0.0015
990 MULTIPLE SCLEROSIS RELAPSE 100 0.0015
991 DRUG ABUSE 121 0.0015
992 DRUG WITHDRAWAL SYNDROME 126 0.0014
993 NO ADVERSE EVENT 251 0.0014
994 ACCIDENTAL EXPOSURE TO PRODUCT 93 0.0009
995 DRUG DEPENDENCE 78 0.0005